Sarepta Therapeutics

About Sarepta Therapeutics

Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates. For more information, please visit


Patient advocacy intern

June 2018 - August 2018 Cambridge, MA
“Enjoyed working in a new and exciting biotech in Boston. The disease states are very fascinating and the policy and advocacy efforts around gene therapy and clinical trials helped me understand where I’d like to take my career in the future ”
See All